{"nct_id":"NCT04898634","title":"A Study of JNJ-78278343, a T-Cell-Redirecting Agent Targeting Human Kallikrein 2 (KLK2), for Advanced Prostate Cancer","status":"ACTIVE_NOT_RECRUITING","status_verified_date":"2025-09","start_date":"2021-07-13","start_date_type":"ACTUAL","primary_completion_date":"2026-02-13","primary_completion_date_type":"ESTIMATED","completion_date":"2026-02-16","completion_date_type":"ESTIMATED","phases":["PHASE1"],"tickers":["JNJ"]}